GESELLSCHAFT FÜR THROMBOSE- UND HÄMOSTASEFORSCHU..
68th GTH Scientific Meeting 2024February 27th - March 1st, 2024 Vienna
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| T10-03 | Platelet function analyzer (PFA-100) in patients with bleeding disorder of unknown cause | Dino Mehic |  Received |
 |
|||
| T11-4 | Identification of an Unmet Medical Need Height of Depression, Hypersomnia and Sleep Apnea Positively Correlate with the Level of Fatigue in Patients with Immune Thrombocytopenia | Rosa Sonja Alesci | Received |
|
|||
| T08-06 | Endemic Struma Nodosa in European Patients with Factor XI Deficiency | Susan Halimeh | Received |
|
|||
| T06-07 | Cellular Components in Whole Blood Contribute to the Development of Thromboembolic Events in Patients with Pancreatic Cancer | Ruth Willems | Received |
|
|||
| T18-07 | Assessment of Emicizumab and Factor VIII using Clot Waveform Analysis | Thomas Siegemund | Received |
|
|||
| T16-07 | Comparison of two automated thrombin generation methods, ST Genesia and Ceveron alpha, during pregnancy with inherited thrombophilia. | Julia Luterán | Received |
|
|||
| T13-8 | Dynamic changes in Factor XIII activity as predictors of mortality in critically ill COVID-19 patients | Christopher Cibis | Received |
|
|||
| T18-08 | A normal range study for the T-TAS(R) with three different chips | Kolde Hans-Jürgen | Received |
|
|||
| T13-09 | Daratumumab as a Well-Tolerated Treatment Option for Acquired Hemophilia A in a Frail Elderly Patient | Lea Kausche | Received |
|
|||
| T18-09 | False Normalisation of Antithrombin in Xa-DOAC treated patients | KIERON HICKEY | Received |
|
|||
| T13-10 | Thromboprophylaxis in 474 pregnancies in women with a positive family history or symptomatic VTE: a prospective two center follow-up study | Rafael Beck | Received |
|
|||
| T07-10 | New inSight Joint Health tool: Focusing on long-term joint health | Anke Tripp Dr | Received |
|
|||
| T18-10 | Expert consensus on an algorithm for rapid exclusion of clinically relevant plasma levels of direct oral anticoagulants in patients using the DOAC Dipstick | Job Harenberg | Received |
|
|||
| T07-16 | Change in Hemophilia Joint Health Score (HJHS) During the Phase 3 XTEND-1 Study of Efanesoctocog Alfa in Patients With Severe Hemophilia A | Elisabeth Bauer | Received |
|
|||
| T07-17 | Development of a digital patient decision aid for bleeding prophylaxis in severe hemophilia A | Florian Langer | Received |
|
|||
| T07-18 | Treatment of Bleeding Episodes With Efanesoctocog Alfa in Patients With Severe Haemophilia A in the Phase 3 XTEND-1 Study | Elisabeth Bauer | Received |
|
|||
| T07-23 | Development of a low-titer inhibitor in a boy with congenital mild hemophilia A: clinical and immunological follow up of 1 year | Karin Ivonne Wieland | Received |
|
|||
| T07-32 | Emicizumab Prophylaxis for the Treatment of Infants with Severe Haemophilia A without Factor VIII Inhibitors: Primary Analysis of the HAVEN 7 Study | Petra Joestingmeyer | Received |
|
|||
| T07-40 | Angiodysplasia and other Vascular Structural Changes in Von Willebrand Disease | Stefanie Lehner | Received |
|
|||
| T07-42 | Enhancing Joint Health in Hemophilic Patients: A Retrospective Cohort Study on Early Detection and Intervention for Synovitis | Susan Halimeh | Received |
|
|||
| T07-43 | Understanding the Psychosocial Impact on Hemophilia Carriers | Dirk Heinrichs | Received |
|
|||
| T07-46 | HEM-POWR study: Fourth interim analysis evaluating real-world effectiveness and safety of damoctocog alfa pegol in previously treated patients with haemophilia A in Germany | Wolfgang Miesbach | Received |
|
|||
68th GTH Scientific Meeting 2024
February 27th - March 1st, 2024 Vienna
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 27/02/2024 TO 27/02/2024
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
|
|
